| A review of clinical outcomes of CAR T-cell therapies for B-acute lymphoblastic leukemia M Martino, C Alati, FA Canale, G Musuraca, G Martinelli, C Cerchione International Journal of Molecular Sciences 22 (4), 2150, 2021 | 82 | 2021 |
| Letermovir prophylaxis for cytomegalovirus infection in allogeneic stem cell transplantation: a real-world experience M Martino, A Pitino, M Gori, B Bruno, A Crescimanno, V Federico, ... Frontiers in oncology 11, 740079, 2021 | 25 | 2021 |
| CART-cell therapy: recent advances and new evidence in multiple myeloma M Martino, FA Canale, C Alati, ID Vincelli, T Moscato, G Porto, B Loteta, ... Cancers 13 (11), 2639, 2021 | 24 | 2021 |
| Spotlight on melphalan flufenamide: An up-and-coming therapy for the treatment of myeloma F Morabito, G Tripepi, EA Martino, E Vigna, F Mendicino, L Morabito, ... Drug Design, Development and Therapy, 2969-2978, 2021 | 11 | 2021 |
| Dexamethasone, oxaliplatin and cytarabine (R-DHAOx) as salvage and stem cells mobilizing therapy in relapsed/refractory diffuse large B cell lymphomas L Manconi, E Coviello, F Canale, L Giannoni, P Minetto, F Guolo, ... Leukemia & lymphoma 61 (1), 84-90, 2020 | 11 | 2020 |
| Chimeric antigen receptor T-cell therapy: what we expect soon M Martino, V Naso, B Loteta, FA Canale, M Pugliese, C Alati, G Musuraca, ... International Journal of Molecular Sciences 23 (21), 13332, 2022 | 10 | 2022 |
| Cutaneous manifestations of hematologic malignancies the experience of an Italian dermatology department G Merlo, E Cozzani, F Canale, M Miglino, M Gambella, M Burlando, ... Hematological Oncology 37 (3), 285-290, 2019 | 8 | 2019 |
| Do CAR-T and Allogeneic Stem Cell Transplant Both Have a Place in Lymphoid Neoplasms? M Martino, FA Canale, V Naso, G Porto, D Gerace, A Allegra International Journal of Molecular Sciences 24 (2), 1045, 2023 | 4 | 2023 |
| Netupitant/palonosetron without dexamethasone for preventing nausea and vomiting in patients with multiple myeloma receiving high-dose melphalan for autologous stem cell … B Loteta, A Paviglianiti, V Naso, A Ferreri, T Moscato, G Console, ... Supportive Care in Cancer 30, 585-591, 2022 | 4 | 2022 |
| Integrating CAR-T cell therapy into the management of DLBCL: what we are learning M Martino, FA Canale, G Porto, C Verduci, G Utano, G Policastro, ... Expert Opinion on Biological Therapy 23 (12), 1277-1285, 2023 | 2 | 2023 |
| The Role of MicroRNA in Graft-versus-Host-Disease: A Review M Pitea, FA Canale, G Porto, C Verduci, G Utano, G Policastro, C Alati, ... Genes 14 (9), 1796, 2023 | 2 | 2023 |
| Effectiveness of biosimilar pegfilgrastim in patients with multiple myeloma after high-dose melphalan and autologous stem cell transplantation M Martino, M Gori, G Porto, M Pellicano, L Santoro, C Verduci, FA Canale, ... Annals of Hematology 102 (7), 1915-1925, 2023 | 2 | 2023 |
| Identifying and managing CAR T-cell–mediated toxicities: on behalf of an Italian CAR-T multidisciplinary team M Martino, S Macheda, U Aguglia, L Arcudi, G Pucci, B Martino, ... Expert Opinion on Biological Therapy 22 (3), 407-421, 2022 | 2 | 2022 |
| Feasibility and efficacy of post-transplant consolidation immunotherapy with nivolumab supported by the reinfusion of unselected autologous lymphocytes in patients affected by … F Guolo, P Minetto, F Ballerini, FA Canale, M Frello, E Coviello, L Manconi, ... Blood 132, 4598, 2018 | 2 | 2018 |
| Case Report: CAR‐T cells and subsequent maintenance with ponatinib in an adult Philadelphia acute lymphoblastic leukemia patient with hematological and extramedullary relapse … FA Canale, M Pitea, C Alati, G Porto, G Pratico, G Utano, J Germanò, ... European Journal of Haematology 112 (1), 137-140, 2024 | 1 | 2024 |
| Effectiveness of CAR-T treatment toward the potential risk of second malignancies M Martino, G Porto, G Policastro, C Alati, B Loteta, MC Micó, C Argiró, ... Frontiers in Immunology 15, 1384002, 2024 | | 2024 |
| THIOTEPA-TREOSULFAN-FLUDARABINE (TTF) AS CONDITIONING REGIMEN IN PATIENTS UNDERGOING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (ALLOHSCT) FOR MYELOFIBROSIS FA Canale, G Porto, C Verduci, M Celentano, B Loteta, M Pugliese, ... BONE MARROW TRANSPLANTATION 58 (SUPP 1), 496-497, 2023 | | 2023 |
| Correction to: Effectiveness of biosimilar pegfilgrastim in patients with multiple myeloma after high‑dose melphalan and autologous stem cell transplantation M Martino, M Gori, G Porto, M Pellicano, L Santoro, C Verduci, FA Canale, ... Annals of Hematology 102 (8), 2297-2298, 2023 | | 2023 |
| The power of telemedicine to improve CAR-T cell therapy programs: lessons learned from COVID-19 pandemic FA Canale, M Martino, G Porto, C Verduci, G Console, G Irrera, B Loteta, ... Supportive Care in Cancer 31 (6), 350, 2023 | | 2023 |
| Thiotepa-treosulfan-fludarabine (ttf) as conditioning regimen in patients undergoing allogeneic hematopoietic stem cell transplantation (allohsct) for myelofibrosis or … FA Canale, G Porto, PF Provenzano, V Naso, T Moscato, M Pugliese, ... BONE MARROW TRANSPLANTATION 57 (SUPPL 1), 236-236, 2022 | | 2022 |
